TMAO: a potential mediator of clopidogrel resistance

Trimethylamine-N-oxide (TMAO) can activate platelets and increase thrombosis risk in clinical and experimental models. Meanwhile, the patients with coronary artery disease have higher serum TMAO level. However, it remains unknown whether Clopidogrel Resistance (CR) could be attributed to TMAO. The p...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Ruisong, Fu, Wenwen, Zhang, Jing, Hu, Xiaorong, Yang, Jun, Jiang, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985207/
https://www.ncbi.nlm.nih.gov/pubmed/33753834
http://dx.doi.org/10.1038/s41598-021-85950-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985207/
https://www.ncbi.nlm.nih.gov/pubmed/33753834
http://dx.doi.org/10.1038/s41598-021-85950-8

Ejemplares similares